M&A Deal Summary |
|
|---|---|
| Date | 2022-03-09 |
| Target | Akorn - Ophthalmic Products |
| Sector | Medical Products |
| Buyer(s) | Théa |
| Sellers(s) | Akorn |
| Deal Type | Divestiture |
SEARCH BY
Théa is an independent pharmaceutical company specialized in the research, development, and commercialization of eye-care products. Théa is based in Clermont-Ferrand, France.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: Illinois M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2022 M&A | 1 of 1 |
| Category | Company |
|---|---|
| Founded | 1971 |
| Sector | Life Science |
| Employees | 1,972 |
| Revenue | 1.1B USD (2016) |
Akorn, Inc. is a niche generic pharmaceutical company engaged in the development, manufacture and marketing of multi-source and branded pharmaceutical products in the areas of ophthalmology, antidotes, anti-infectives, and controlled substances for pain management and anesthesia in the United States and across the globe. Akorn, Inc. was founded in 1971 and is based in Lake Forest, Illinois.
| DEAL STATS | # |
|---|---|
| Overall | 4 of 4 |
| Sector: Medical Products M&A | 2 of 2 |
| Type: Divestiture M&A Deals | 3 of 3 |
| State: Illinois M&A | 2 of 2 |
| Country: United States M&A | 4 of 4 |
| Year: 2022 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-05-27 |
Akorn - Consumer Health Business
Lake Forest, Illinois, United States Akorn's Consumer Health Business primarily consists of the following over-the-counter brands: TheraTears, Diabetic Tussin, MagOx, Multi-betic, and Zostrix. The business optimizes the core prescription drug portfolio and enhances our capacity to make growth-oriented investments. |
Sell | $230M |
